Free Trial
ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

Australian Clinical Labs logo

About Australian Clinical Labs Stock (ASX:ACL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
4.96%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

ACL Stock News Headlines

Australian Clinical Labs Issues New Securities
Elon’s New AI Firm REVEALED
Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elon Musk recently teamed up with Nvidia – and another, emerging tech titan…
Australian Clinical Labs Gains New Substantial Investor
Australian Clinical Labs Sees Change in Major Holders
Australian Clinical Labs Optimizes Capital with Buy-Back
Australian Clinical Labs Updates Share Buy-Back Program
See More Headlines

ACL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Coles Group (COL).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

Net Income
$23.93 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$696.37 million
Book Value
A$0.89 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.18
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (ASX:ACL) was last updated on 1/14/2025 by MarketBeat.com Staff
From Our Partners